DBV Technologies S.A.
HealthcareNASDAQ:DBVT · NASDAQ Global Select
+$0.88 today
Vol 0.99M · Avg 0.24M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+91.37%
Period High
$24.54
Period Low
$8.51
Latest
$17.42
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$814.99M
Alto Neuroscience, Inc.
NYSE:ANRO
$753.47M
Annexon, Inc.
NASDAQ:ANNX
$563.29M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$343.14M
Amarin Corporation plc
NASDAQ:AMRN
$315.21M
Cellectis S.A.
NASDAQ:CLLS
$310.29M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$296.96M
Altimmune, Inc.
NASDAQ:ALT
$230.35M
Korro Bio, Inc.
NASDAQ:KRRO
$115.56M
enGene Holdings Inc.
NASDAQ:ENGN
$82.94M
What is the latest DBVT filing?
The latest filing shown is 8-K dated Jun 5, 2026.
How many recent filings does DBVT have?
Intrinsic Alpha currently shows 20 recent filings for DBVT.
Explore More
Continue the stock analysis
Jump to another research area for this company.